According to a new report, published by KBV research, The Global Electrosurgery Market size is expected to reach $8.4 billion by 2028, rising at a market growth of 5.9% CAGR during the forecast period.
The Electrosurgical Instruments segment acquired maximum revenue share in the Global Electrosurgery Market by Product in 2021 achieving a market value of $3.7 billion by 2028. A handpiece with one or more electrodes and a generator makes up an electrosurgical unit (ESU). A foot switch or a switch on the handpiece is used to operate the gadget. These waveforms change along with the associated tissue effects.
The Ambulatory Surgical Centers segment has shown the growth rate of 6.1% during (2022 - 2028). It is because these healthcare facilities provide advantages including lower wait times and significant cost reductions. The high desire for minimally invasive treatments and shorter stays in hospitals in ASCs are other factors driving the category.
The General Surgery segment is leading the Global Electrosurgery Market by Surgery in 2021 thereby, achieving a market value of $1.9 billion by 2028. It is because the goal of general surgery is to treat problems with the gastrointestinal tract, including the esophagus, stomach, small and large intestines, liver, pancreas, gallbladder, appendix, bile ducts, and frequently the thyroid gland.
The North America market dominated the Global Electrosurgery Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.9 billion by 2028. The Asia Pacific market is exhibiting a CAGR of 6.5% during (2022 - 2028). Additionally, The Europe market would showcase a CAGR of 5.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/electrosurgery-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Boston Scientific Corporation, Johnson & Johnson (Ethicon, Inc.), Olympus Corporation, ConMed Corporation, Smith & Nephew PLC, Utah Medical Products, Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings, Inc., and The Cooper Companies, Inc.
By Product
By End User
By Surgery
By Geography
Companies Profiled
Unique Offerings 
